Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSamsung El.gdr Regulatory News (SMSN)

Share Price Information for Samsung El.gdr (SMSN)

Share Price is delayed by 15 minutes
Get Live Data
5,075.00    -515.00 (-9.21%)
Bid:
5,060.00
Ask:
5,065.00
Spread: 5.00 (0.099%)
Market Cap: $1.33t
SMSN Live PriceLast checked at - London Stock Exchange

Intraday Samsung El.gdr Share Chart

  • This share is an international stock.

Shareholder Return Program for FY2018-2020

31 Oct 2017 07:00

RNS Number : 0625V
Samsung Electronics Co. Ld
31 October 2017
 

Shareholder Return Program for FY2018-2020

Samsung Electronics Co., Ltd. (KS005930, KS005935, SMSN, SMSD) ("SEC") announced today that its Board of Directors at their meeting on October 31, 2017 approved a shareholder return program for FY2018-2020. The core strategy of the policy enhancement is to provide investor community with greater predictability on the returns program.

· The company will increase annual dividends for FY2017 by 20 percent compared to that of FY2016, which will be followed by a 100 percent rise in dividends for FY2018 compared to that of FY2017. The FY2019 and FY2020 dividends will be kept at the same level with that of FY2018.

· Future M&A investments will not be deducted from free cash flow (FCF). This policy change will prevent the amount of capital available to return to shareholders from decreasing and result in greater transparency and predictability.

· The company will change the standard period of returning minimum 50% of FCF from a one-year basis to a three-year basis. This is to address steep fluctuation of annual shareholder return resulting from fluctuation of the annual FCF. After dividend payouts, any remaining portion of the 50% of FCF available for shareholder returns will be used either for additional cash dividends or share buybacks as deemed appropriate.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUAOURBNARORA
Date   Source Headline
29th Aug 20258:57 amRNS2025 Half-year Business Report
31st Jul 20259:49 amRNSReport on Share Disposition Results
31st Jul 20259:48 amRNSTransaction with Affilliate Company
31st Jul 20258:55 amRNSSingle Sale and Supply Contract - Replacement
31st Jul 20257:00 amRNSQuarterly Dividend for Second Quarter 2025
31st Jul 20257:00 amRNS2025 2Q Earnings Release
28th Jul 20259:19 amRNSSingle Sale and Supply Contract
25th Jul 20259:53 amRNSDecision on Share Disposition
8th Jul 20258:11 amRNSDecision on Share Repurchase
8th Jul 20257:15 amRNSNotice of 2Q 2025 Earning Release schedule
8th Jul 20257:09 amRNS2Q 2025 Pre-Earnings Guidance
27th Jun 20258:51 amRNSSustainability Report 2025
30th May 20259:58 amRNSCorporate Governance Report FY2024
30th May 20259:49 amRNS2025 1Q Interim Business Report
28th May 202510:10 amRNSReport on Share Disposition Results
23rd May 20259:36 amRNSDecision on Share Disposition
16th May 20259:34 amRNSReport on Share Repurchase Results
30th Apr 20259:05 amRNS2024 Business Report
30th Apr 20258:45 amRNSCharitable Contribution
30th Apr 20258:42 amRNSTransactions with Affiliated Companies
30th Apr 20257:00 amRNS2025 1Q Earnings Release
30th Apr 20257:00 amRNSQuarterly Dividend for First Quarter 2025
8th Apr 20257:00 amRNSNotice of 1Q 2025 Earning Release schedule
8th Apr 20257:00 amRNS1Q 2025 Pre-Earnings Guidance
26th Mar 20257:00 amRNSNotice on Change of Chief Executive Officer
19th Mar 20258:16 amRNSAppointment of New Chief Executive Officer
19th Mar 20258:11 amRNSResults of the 56th Annual General Meeting
18th Feb 202510:21 amRNSDecision on Share Repurchase
18th Feb 202510:07 amRNSCharitable Contribution
18th Feb 20259:57 amRNSDecision on Cancellation of Shares
18th Feb 20259:14 amRNSReference Material for 2025 AGM
18th Feb 20259:01 amRNS2024 Separate Financial Statements
18th Feb 20258:58 amRNS2024 Consolidated Financial Statements
17th Feb 202512:16 pmRNSReport on Share Repurchase Results
13th Feb 20259:12 amRNSFinal Delisting and Listing of Stocks
13th Feb 20258:42 amRNSAdmission to Trading
10th Feb 202512:05 pmRNSNotice of Approval and Publication of Prospectus
31st Jan 20257:00 amRNS2024 4Q Earning Release
31st Jan 20257:00 amRNSYear-End Dividend for FY2024
31st Jan 20257:00 amRNSAnnouncement of Capex Result for FY2024
8th Jan 20257:00 amRNS4Q 2024 Pre-Earnings Guidance
8th Jan 20257:00 amRNSNotice of 4Q 2024 Earning Release
23rd Dec 20247:00 amRNSInvestment in New Semiconductor Plant in Texas, US
29th Nov 20248:01 amRNSCharitable Contribution
29th Nov 20247:55 amRNS2024 3Q Interim Business Report
29th Nov 20247:41 amRNSTransaction with Affiliate Company
26th Nov 202410:01 amRNSDelisting of GDR from the LuxembourgStockExchange
18th Nov 20249:22 amRNSDecision on Share Repurchase Plan
4th Nov 202410:05 amRNSDelisting Announcement
31st Oct 20249:14 amRNSCharitable Contribution

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.